EMPLOYMENT AGREEMENTEmployment Agreement • February 20th, 2019 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
EMPLOYMENT AGREEMENT (the "Agreement") dated as of November 22, 2013 by and between Lantheus Medical Imaging, Inc., a Delaware corporation (the "Company") and Michael Duffy ("Executive").
VIA HAND DELIVERY [Name] C/O Lantheus Medical Imaging, Inc. North Billerica, MA 01862Letter Agreement • February 20th, 2019 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
This letter agreement (this “Agreement”) sets forth the terms and conditions pursuant to which Lantheus Medical Imaging, Inc., a Delaware corporation (the “Company”), will pay you cash severance if your employment with the Company is terminated in a Qualifying Termination (as defined below). Following your execution of this Agreement, the severance payments and benefits described in this Agreement will be the only severance payments or benefits that you will be entitled to in connection with a termination of your employment and you will not be entitled to any severance payments or benefits under the terms of any other agreement with the Company, including, without limitation, that certain Employment Agreement, dated as of [________] (collectively, and with any and all amendments, the “Employment Agreement”), or any plan, policy or program of the Company.
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 20th, 2019 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • New York
This SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), effective as of January 25, 2019 by and between Lantheus Medical Imaging, Inc., a Delaware corporation (the “Company”) and Mary Anne Heino (“Executive”), amends and restates in its entirety her employment agreement, as previously amended and restated and subsequently amended, and as in effect immediately prior to giving effect hereto (collectively, the “Existing Agreement”).
VIA HAND DELIVERY [Name] C/O Lantheus Medical Imaging, Inc.Letter Agreement • February 20th, 2019 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
